SOTALOL HYDROCHLORIDE (Sotalol Hydrochloride) Patent Expiration, LOE Window & CMS Spending

SOTALOL HYDROCHLORIDE (Sotalol Hydrochloride) by Altathera: FDA Orange Book LOE 2039-08-21, 0 AB generics, $0 2024 CMS Part D & Medicaid spend, and 4 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorAltathera
FDA Application & PathwayN022306 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2039-08-21
Orange Book Patents (*PED Extensions)10 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$0
2024 Medicare Part D Spend$0
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)4 WAC filings (max 32.8% 2-yr change)